What the team is known for
Davis Polk & Wardwell fields a respected transactional team with considerable M&A expertise, admired for its representation of high-profile Chinese clients on take-privates, acquisitions and disposals. Also handles significant private equity mandates from its Hong Kong and Beijing offices and often acts for private equity funds and VC investors. Key industry sectors include e-commerce, media and telecommunications. Additionally able to advise on mandates involving India, Taiwan, Thailand and Japan.
"They have rich experiences in dealing with all kinds of tricky issues," reports a client, who says that they are able to "provide valuable and practical solutions, both legally and commercially."
One client compliments the team for having "a lot of local knowledge for doing international standard M&A and PE investments."
A market commentator remarks: "As a top US firm, Davis Polk provides very high-quality service and has a deep insight into Japanese companies and M&A practices in Japan."
Davis Polk & Wardwell advised Switzerland-headquartered company ADC Therapeutics with its joint venture arrangement with Overland Pharmaceuticals in connection with antibody drug development and commercialisation.
Davis Polk & Wardwell advised Shiseido on the transfer of its global personal care business to CVC Asia Pacific, in a transaction valued at approximately USD1.52 billion.
Davis Polk & Wardwell assisted the special committee of Chinese human resource platform 51job with the acquisition proposed by DCP Capital Partners.
Miranda So and Howard Zhang are key contacts in Hong Kong and Beijing respectively. Ken Lebrun heads the corporate team in Tokyo.